Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.

Pavesio C, Zierhut M, Bairi K, Comstock TL, Usner DW; Fluocinolone Acetonide Study Group..

Ophthalmology. 2010 Mar;117(3):567-75, 575.e1. doi: 10.1016/j.ophtha.2009.11.027.

PMID:
20079922
2.

Postoperative infection in penetrating versus non-penetrating glaucoma surgery.

Ang GS, Varga Z, Shaarawy T.

Br J Ophthalmol. 2010 Dec;94(12):1571-6. doi: 10.1136/bjo.2009.163923. Review.

PMID:
19897472
3.
4.

Basic quantitative assessment of visual performance in patients with very low vision.

Bach M, Wilke M, Wilhelm B, Zrenner E, Wilke R.

Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1255-60. doi: 10.1167/iovs.09-3512.

PMID:
19850846
5.

Risk factors for pseudophakic retinal detachment after intraocular lens scleral fixation with or without pars plana vitrectomy.

Kim SW, Kim MJ, Yang KS, Sohn JH, Huh K.

Retina. 2009 Nov-Dec;29(10):1479-85. doi: 10.1097/IAE.0b013e3181aade61.

PMID:
19696697
6.

Three-year follow-up of the tube versus trabeculectomy study.

Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL; Tube Versus Trabeculectomy Study Group..

Am J Ophthalmol. 2009 Nov;148(5):670-84. doi: 10.1016/j.ajo.2009.06.018.

PMID:
19674729
7.

Brightness as a function of current amplitude in human retinal electrical stimulation.

Greenwald SH, Horsager A, Humayun MS, Greenberg RJ, McMahon MJ, Fine I.

Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5017-25. doi: 10.1167/iovs.08-2897.

8.

Feasibility study of a retinal prosthesis: spatial vision with a 16-electrode implant.

Caspi A, Dorn JD, McClure KH, Humayun MS, Greenberg RJ, McMahon MJ.

Arch Ophthalmol. 2009 Apr;127(4):398-401. doi: 10.1001/archophthalmol.2009.20.

PMID:
19365014
9.

Predicting visual sensitivity in retinal prosthesis patients.

Horsager A, Greenwald SH, Weiland JD, Humayun MS, Greenberg RJ, McMahon MJ, Boynton GM, Fine I.

Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1483-91. doi: 10.1167/iovs.08-2595.

10.

Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.

Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L, Conlon TJ, Boye SL, Flotte TR, Byrne BJ, Jacobson SG.

Hum Gene Ther. 2008 Oct;19(10):979-90. doi: 10.1089/hum.2008.107.

11.

Resolving the clinical acuity categories "hand motion" and "counting fingers" using the Freiburg Visual Acuity Test (FrACT).

Lange C, Feltgen N, Junker B, Schulze-Bonsel K, Bach M.

Graefes Arch Clin Exp Ophthalmol. 2009 Jan;247(1):137-42. doi: 10.1007/s00417-008-0926-0.

PMID:
18766368
12.

Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium.

Radtke ND, Aramant RB, Petry HM, Green PT, Pidwell DJ, Seiler MJ.

Am J Ophthalmol. 2008 Aug;146(2):172-182. doi: 10.1016/j.ajo.2008.04.009.

13.

Factors affecting perceptual thresholds in epiretinal prostheses.

de Balthasar C, Patel S, Roy A, Freda R, Greenwald S, Horsager A, Mahadevappa M, Yanai D, McMahon MJ, Humayun MS, Greenberg RJ, Weiland JD, Fine I.

Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2303-14. doi: 10.1167/iovs.07-0696.

14.

Comparison of single thickness and double thickness processed pericardium patch graft in glaucoma drainage device surgery: a single surgeon comparison of outcome.

Lankaranian D, Reis R, Henderer JD, Choe S, Moster MR.

J Glaucoma. 2008 Jan-Feb;17(1):48-51. doi: 10.1097/IJG.0b013e318133fc49.

PMID:
18303385
15.

Stem cell therapy and the retina.

MacLaren RE, Pearson RA.

Eye (Lond). 2007 Oct;21(10):1352-9. Review.

PMID:
17914439
16.

Full-field stimulus testing (FST) to quantify visual perception in severely blind candidates for treatment trials.

Roman AJ, Cideciyan AV, Aleman TS, Jacobson SG.

Physiol Meas. 2007 Aug;28(8):N51-6.

PMID:
17664667
17.

Long-term safety and functional outcome of combined pars plana vitrectomy and scleral-fixated sutured posterior chamber lens implantation.

Bading G, Hillenkamp J, Sachs HG, Gabel VP, Framme C.

Am J Ophthalmol. 2007 Sep;144(3):371-377.

PMID:
17624290
18.

Visual performance using a retinal prosthesis in three subjects with retinitis pigmentosa.

Yanai D, Weiland JD, Mahadevappa M, Greenberg RJ, Fine I, Humayun MS.

Am J Ophthalmol. 2007 May;143(5):820-827.

PMID:
17362868
19.

Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.

Jaffe GJ, Martin D, Callanan D, Pearson PA, Levy B, Comstock T; Fluocinolone Acetonide Uveitis Study Group..

Ophthalmology. 2006 Jun;113(6):1020-7.

PMID:
16690128
20.

Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.

Kappel PJ, Charonis AC, Holland GN, Narayanan R, Kulkarni AD, Yu F, Boyer DS, Engstrom RE Jr, Kuppermann BD; Southern California HIV/Eye Consortium..

Ophthalmology. 2006 Apr;113(4):683.e1-8.

PMID:
16581428
Items per page

Supplemental Content

Support Center